| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 13 |
| 1 | CALCIUM | 8 |
| 2 | CALCITRIOL | 6 |
| 3 | CALCITRIOL CAPSULES 0.25 MCG | 6 |
| 4 | CALCITRIOL CAPSULES 0.5 MCG | 6 |
| 5 | ANTACID | 5 |
| 6 | CALCIUM CARBONATE | 5 |
| 7 | POTASSIUM CHLORIDE | 5 |
| 8 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 5 |
| 9 | POTASSIUM CHLORIDE ORAL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBANDRONATE SODIUM | 1 | 0.0003 |
| 1 | CALCITRIOL CAPSULES 0.25 MCG | 6 | 0.0003 |
| 2 | ROMOSOZUMAB-AQQG | 3 | 0.0002 |
| 3 | ALECTINIB HYDROCHLORIDE | 1 | 0.0001 |
| 4 | ERGOCALCIFEROL | 3 | 0.0001 |
| 5 | ABALOPARATIDE | 3 | 0.0001 |
| 6 | ADALIMUMAB-FKJP | 4 | 0.0001 |
| 7 | CANDESARTAN | 3 | 0.0001 |
| 8 | ADALIMUMAB-AATY | 4 | 0.0001 |
| 9 | CALCIUM CARBONATE | 5 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | RANK Ligand Inhibitor [EPC] | 13 |
| 1 | Calcium [EPC] | 8 |
| 2 | Vitamin D3 Analog [EPC] | 6 |
| 3 | Osmotic Laxative [EPC] | 5 |
| 4 | Potassium Salt [EPC] | 5 |
| 5 | Aldosterone Antagonist [EPC] | 4 |
| 6 | Corticosteroid [EPC] | 4 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 4 |
| 8 | Parathyroid Hormone-Related Peptide Analog [EPC] | 3 |
| 9 | Provitamin D2 Compound [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D3 Analog [EPC] | 6 | 0.0003 |
| 1 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 2 | Parathyroid Hormone-Related Peptide Analog [EPC] | 3 | 0.0001 |
| 3 | RANK Ligand Inhibitor [EPC] | 13 | 0.0001 |
| 4 | Calcium [EPC] | 8 | 0.0001 |
| 5 | Aldosterone Antagonist [EPC] | 4 | 0.0000 |
| 6 | Osmotic Laxative [EPC] | 5 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 4 | 0.0000 |